Skip to main content

How Effective is Atomoxetine in Children and Adolescents?

https://www.thecarlatreport.com/podcast/how-effective-is-atomoxetine-in-children-and-adolescents/

 

Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine. How effective is it? What are some of its pros and cons? This podcast will clarify the position of atomoxetine in our toolbox for treating children and adolescents with ADHD. 

Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

How Autism Affects Custody Battles

How Autism Affects Custody Battles

Decisions made during custody or visitation disputes can be life-altering. Autism adds another layer of complexity to the challenge. Read about the benefits of an expert’s contribution when autism affects custody battles.
 college supplies

Navigating the Transition to College

In this podcast, Mara and I talk about the transition to college which can be challenging for any adolescent, and even mores when dealing with other mental health concerns,.

Government Benefits for Autism

When you have autism, accessing essential financial support through programs like Supplemental Security Income (SSI) can seem impossible. Dr. Feder can help you conquer the complexities of SSI and other government assistance programs.

Congenital Disorders in Psychiatry: Screening & Management

Catch these conditions and offer meaningful help! Join Dr Josh Feder and Mara Goverman, LCSW with our guest Dr. MARILYN JONES, MD as we talk about early identification, testing, and strategies for individuals and families affected by genetic disorders.